These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 39032830)

  • 1. Clinical and Economic Burden of Severe Asthma With Low Blood Eosinophil Counts.
    Busby J; Menon S; Martin N; Lipworth J; Zhang R; Burhan H; Brown T; Chaudhuri R; Gore R; Jackson DJ; Naveed S; Pantin T; Pfeffer PE; Patel M; Patel PH; Rupani H; Heaney LG
    J Allergy Clin Immunol Pract; 2024 Oct; 12(10):2785-2797. PubMed ID: 39032830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.
    Price DB; Rigazio A; Campbell JD; Bleecker ER; Corrigan CJ; Thomas M; Wenzel SE; Wilson AM; Small MB; Gopalan G; Ashton VL; Burden A; Hillyer EV; Kerkhof M; Pavord ID
    Lancet Respir Med; 2015 Nov; 3(11):849-58. PubMed ID: 26493938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood eosinophil count group shifts and kinetics in severe eosinophilic asthma.
    Lugogo NL; Kreindler JL; Martin UJ; Cook B; Hirsch I; Trudo FJ
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):171-176. PubMed ID: 32334141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Tran TN
    J Allergy Clin Immunol Pract; 2017; 5(4):1050-1060.e9. PubMed ID: 28215604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN
    J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials.
    Bernstein JA; Virchow JC; Murphy K; Maspero JF; Jacobs J; Adir Y; Humbert M; Castro M; Marsteller DA; McElhattan J; Hickey L; Garin M; Vanlandingham R; Brusselle G
    Lancet Respir Med; 2020 May; 8(5):461-474. PubMed ID: 32066536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies.
    Goldman M; Hirsch I; Zangrilli JG; Newbold P; Xu X
    Curr Med Res Opin; 2017 Sep; 33(9):1605-1613. PubMed ID: 28644104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and disease burden of severe eosinophilic asthma in Japan.
    Nagasaki T; Sato K; Kume N; Oguma T; Sunadome H; Ito I; Izuhara Y; Okamoto K; Kobayashi S; Ohno T; Mizukami A; Kobayashi A; Kaise T; Kuroda T; Mishima M; Matsumoto H
    J Asthma; 2019 Nov; 56(11):1147-1158. PubMed ID: 30822174
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
    COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of illness in blood eosinophilic phenotype COPD patients in New Zealand.
    Shantakumar S; Ho YF; Beale J; Gribben B
    Respir Investig; 2021 Jul; 59(4):487-497. PubMed ID: 33994346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic Differences in Severe Asthma Clinical Care and Outcomes: An Analysis of United Kingdom Primary and Specialist Care.
    Busby J; Heaney LG; Brown T; Chaudhuri R; Dennison P; Gore R; Jackson DJ; Mansur AH; Menzies-Gow A; Message S; Niven R; Patel M; Price D; Siddiqui S; Stone R; Pfeffer PE;
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):495-505.e2. PubMed ID: 34626858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Implications of Longitudinal Blood Eosinophil Counts in Patients With Severe Asthma.
    Bleecker ER; Meyers DA; Billheimer D; Li H; Newbold P; Kwiatek J; Hirsch I; Katial R; Li X
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1805-1813. PubMed ID: 36868471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of exacerbations and blood eosinophils in UK and US COPD populations.
    Vogelmeier CF; Kostikas K; Fang J; Tian H; Jones B; Morgan CL; Fogel R; Gutzwiller FS; Cao H
    Respir Res; 2019 Aug; 20(1):178. PubMed ID: 31391053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of short-term pausing of oral corticosteroids on blood eosinophil count in patients with severe asthma.
    Biener L; Milger K; Suhling H; Korn S; Pizarro C; Skowasch D
    Pneumologie; 2023 Jun; 77(6):357-362. PubMed ID: 36384226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization.
    Viinanen A; Lassenius MI; Toppila I; Karlsson A; Veijalainen L; Idänpään-Heikkilä JJ; Laitinen T
    J Asthma; 2020 Oct; 57(10):1092-1102. PubMed ID: 31267775
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
    Ortega HG; Yancey SW; Mayer B; Gunsoy NB; Keene ON; Bleecker ER; Brightling CE; Pavord ID
    Lancet Respir Med; 2016 Jul; 4(7):549-556. PubMed ID: 27177493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
    Heaney LG; Busby J; Hanratty CE; Djukanovic R; Woodcock A; Walker SM; Hardman TC; Arron JR; Choy DF; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Mansur AH; Fowler SJ; Niven RM; Howarth PH; Lordan JL; Menzies-Gow A; Harrison TW; Robinson DS; Holweg CTJ; Matthews JG; Pavord ID;
    Lancet Respir Med; 2021 Jan; 9(1):57-68. PubMed ID: 32916135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era.
    Jackson DJ; Busby J; Pfeffer PE; Menzies-Gow A; Brown T; Gore R; Doherty M; Mansur AH; Message S; Niven R; Patel M; Heaney LG;
    Thorax; 2021 Mar; 76(3):220-227. PubMed ID: 33298582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain.
    Sicras-Mainar A; Capel M; Navarro-Artieda R; Nuevo J; Orellana M; Resler G
    J Med Econ; 2020 May; 23(5):492-500. PubMed ID: 31958257
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma.
    Papi A; Ryan D; Soriano JB; Chrystyn H; Bjermer L; Rodríguez-Roisin R; Dolovich MB; Harris M; Wood L; Batsiou M; Thornhill SI; Price DB
    J Allergy Clin Immunol Pract; 2018; 6(6):1989-1998.e3. PubMed ID: 29627457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.